Home › Insurance Coverage › Using an HSA or FSA for Peptides

Using an HSA or FSA for Peptides

A sourced, cited answer on US insurance coverage of peptides, refreshed automatically from live research.

Sometimes Covered

Can you use an HSA or FSA to pay for peptides? You can use HSA/FSA funds for peptides only when the specific peptide is a prescribed, FDA-approved (or FDA-compliant compounded) drug used to treat a diagnosed medical condition -- FDA-approved peptide drugs like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound) for their approved indications generally qualify, while 'research peptides' or anti-aging peptides such as BPC-157, TB-500, or CJC-1295/Ipamorelin are generally NOT reimbursable because they lack a valid prescription for an FDA-recognized medical use.

Important: This is general information, not individualized insurance or medical advice. Coverage depends on your specific plan, and payer policies change. Confirm details with your insurer or plan administrator.

Overview

Whether an HSA or FSA can pay for a peptide depends entirely on IRS Section 213(d) rules for 'qualified medical expenses,' not on a peptide-specific insurance policy. Under IRS Publication 502, a drug must be legally prescribed by a licensed provider to treat, mitigate, or prevent a diagnosed disease to qualify; cosmetic or general wellness use is explicitly excluded. This means FDA-approved peptide drugs prescribed on-label (e.g., GLP-1 agonists for diabetes or obesity, growth-hormone peptides for documented deficiency) are typically reimbursable with a prescription or Letter of Medical Necessity, while unapproved 'research-use-only' peptides sold outside a licensed pharmacy chain are usually denied by HSA/FSA administrators because they are not legally prescribed drugs.

Key Points

  • The IRS treats HSA/FSA eligibility as a tax question, not an insurance-coverage question: under IRS Publication 502, a drug expense is reimbursable only if it is a prescribed drug used for medical care, and cosmetic or general-wellness use does not qualify. [1]
  • FDA-approved GLP-1 peptide drugs like semaglutide and tirzepatide are HSA/FSA eligible when prescribed by a physician, including compounded semaglutide, according to HSA-eligibility guidance from weight-loss providers. [2]
  • Semaglutide can qualify for HSA/FSA reimbursement even for weight-related use when the excess weight is tied to a diagnosed condition such as high blood pressure, sleep apnea, or cardiovascular risk, rather than for weight loss alone. [3]
  • Many HSA/FSA administrators require a prescription or a Letter of Medical Necessity (LOMN) from a licensed healthcare provider before they will approve reimbursement for peptide therapy. [4]
  • Cosmetic surgery and similar cosmetic procedures are statutorily excluded from the definition of deductible 'medical care' under IRC Section 213(d)(9), a rule that HSA/FSA administrators apply to deny anti-aging or purely cosmetic peptide use. [5]
  • Popular research peptides such as BPC-157, TB-500, CJC-1295/Ipamorelin, MOTS-c, GHK-Cu, and AOD-9604 are not covered by insurance or reliably reimbursable through HSA/FSA in practice because they are not FDA-approved drugs. [6]
  • BPC-157 is not FDA-approved and does not appear in the FDA's Approved Drugs database, and it sits in regulatory limbo for legal pharmacy compounding, which undermines its status as a 'prescribed drug' for HSA/FSA purposes. [7]
  • Even when a peptide qualifies, HSA/FSA plans can impose their own additional restrictions, such as requiring pre-approval or excluding certain treatments entirely, so eligibility can vary by specific plan administrator. [8]

Sources

Last researched: 2026-08-25